scholarly journals Successful Treatment of Suborbital Pyogenic Granuloma with Topical Imiquimod

2018 ◽  
Vol 07 (01) ◽  
pp. 1-6 ◽  
Author(s):  
George Badavanis ◽  
Efstathia Pasmatzi ◽  
Alexandra Monastirli ◽  
Dionysios Tsambaos
2006 ◽  
Vol 17 (2) ◽  
pp. 121-123 ◽  
Author(s):  
Gary Goldenberg ◽  
Daniel P. Krowchuk ◽  
Joseph L. Jorizzo

2021 ◽  
Author(s):  
Davide Fattore ◽  
Adriana Di Guida ◽  
Aikaterini Detoraki ◽  
Gaia De Fata Salvatores ◽  
Lucia Gallo ◽  
...  

2018 ◽  
Vol 11 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Taku Fujimura ◽  
Yumi Kambayashi ◽  
Yota Sato ◽  
Kayo Tanita ◽  
Sadanori Furudate ◽  
...  

Simultaneous or sequential, planned administration of ipilimumab could significantly enhance the antitumor effects of nivolumab in advanced melanoma patients. On the other hand, the efficacy of ipilimumab for nivolumab-resistant advanced melanoma is extremely poor. Therefore, additional supportive therapy for anti-PD-1 antibody therapy-resistant advanced melanoma has been widely investigated. In this report, we describe a case of multiple in-transit melanomas developing in a nivolumab-resistant patient successfully treated with ipilimumab in combination with imiquimod. Our present case suggested a possible therapy for nivolumab-resistant multiple in-transit melanomas using ipilimumab in combination with topical imiquimod.


1998 ◽  
Vol 47 (6) ◽  
pp. 538-540 ◽  
Author(s):  
Katsuya Hirakawa ◽  
Kunihiko Aoyagi ◽  
Takashi Yao ◽  
Kazuoki Hizawa ◽  
Hideki Kido ◽  
...  

2019 ◽  
Vol 59 (6) ◽  
Author(s):  
Francisco J. Navarro‐Triviño ◽  
Laura Linares‐Gonzalez ◽  
Teresa Ródenas‐Herranz ◽  
Ricardo Ruiz‐Villaverde

2003 ◽  
Vol 49 (4) ◽  
pp. 769-771 ◽  
Author(s):  
Linda C Wang ◽  
Anita Blanchard ◽  
Diane E Judge ◽  
Allan A Lorincz ◽  
Maria M Medenica ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document